Marker Therapeutics, Inc. (MRKR): Shares Outstanding
16.70M
As of 2025-12-31
16.70M
As of 2026-06-30
+25.7%
3-year compound annual growth
| Period ended | Shares Outstanding | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 16.70M | +56.1% | 2026-03-18, Balance as of period end |
| 2024-12-31 | 10.70M | +20.2% | 2026-03-18, Balance as of period end |
| 2023-12-31 | 8.90M | +6.0% | 2025-03-31, Balance as of period end |
| 2022-12-31 | 8.40M | +1.2% | 2024-03-26, Balance as of period end |
| 2021-12-31 | 8.30M | n/c | 2023-03-22, Balance as of period end |
| 2020-12-31 | 50.70M | +10.9% | 2022-03-17, Balance as of period end |
| 2019-12-31 | 45.70M | +0.7% | 2021-03-09, Balance as of period end |
| 2018-12-31 | 45.40M | +328.3% | 2020-03-12, Balance as of period end |
| 2017-12-31 | 10.60M | +26.2% | 2019-03-15, Balance as of period end |
| 2016-12-31 | 8.40M | n/c | 2018-03-23, Balance as of period end |
| 2015-12-31 | 5.88M | n/c | 2017-03-14, Balance as of period end |
| 2014-12-31 | 20.32M | n/m | 2016-04-14, Balance as of period end |
| 2013-12-31 | 1.47M | n/c | 2015-04-15, Balance as of period end |
| 2012-12-31 | 764.0K | -98.5% | 2014-04-17, Balance as of period end |
| 2011-12-31 | 52.07M | +29.4% | 2013-05-15, Balance as of period end |
| 2010-12-31 | 40.26M | n/a | 2012-04-16, Balance as of period end |